Bicara Therapeutics Inc.

BCAX

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0002023658

SEC filings (opens in a new tab)

In the last 90 days, Bicara Therapeutics Inc. insiders filed 0 open-market purchases and 7 sales; 171 institutions reported holding it in 13F filings for Q2 2026, worth $2.07B in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding Bicara Therapeutics Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025 All holders in Q4 2024

13F holders of BCAX: Q4 2024 compared with Q1 2025
Measure	Q4 2024	Of which not filed for Q1 2025	Q1 2025	Change
Holders	84	1	93	+10
Shares	46.7M	25.0K	48.6M	+1.93M (+4.1%)
Value	$813.6M	$436.0K	$633.9M	−$179.3M (−22.0%)

1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (28)

Institutions that held Bicara Therapeutics Inc. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to BCAX in Q1 2025
Institution	Shares	Value	% of portfolio
Schonfeld Strategic Advisors LLC	365,964	$4.77M	0.03%
Napean Trading & Investment Co (Singapore) PTE Ltd	275,942	$3.60M	1.05%
HealthInvest Partners AB	119,833	$1.56M	0.69%
StemPoint Capital LP	47,078	$613.4K	0.20%
Schroder Investment Management Group	41,660	$558.2K	0.00%
Victory Capital Management Inc	34,430	$448.6K	0.00%
Jefferies Financial Group Inc.	30,601	$398.7K	0.01%
Nuveen, LLC	25,028	$326.1K	0.00%
Susquehanna International Group, LLP	24,902	$324.5K	0.00%
AQR Capital Management LLC	19,034	$248.0K	0.00%
Intech Investment Management LLC	16,746	$218.2K	0.00%
Franklin Resources Inc	13,669	$178.1K	0.00%
Two Sigma Investments, LP	12,770	$166.4K	0.00%
Virtus Investment Advisers, Inc.	9,097	$118.5K	0.03%
Avanza Fonder AB	6,653	$88.2K	0.00%
New York State Common Retirement Fund	4,000	$52.1K	0.00%
CWM, LLC	2,198	$29.0K	0.00%
Larson Financial Group LLC	1,070	$13.9K	0.00%
US Bancorp	567	$7.39K	0.00%
Allworth Financial LP	325	$5.08K	0.00%
Nisa Investment Advisors, LLC	163	$2.12K	0.00%
Simplex Trading, LLC	154	$2.00K	0.00%
EverSource Wealth Advisors, LLC	102	$1.33K	0.00%
Signaturefd, LLC	80	$1.04K	0.00%
Lindbrook Capital, LLC	71	$925	0.00%
True Wealth Design, LLC	33	$430	0.00%
Rothschild Investment LLC	20	$261	0.00%
Farther Finance Advisors, LLC	16	$203	0.00%

Sold out (18)

Institutions that held Bicara Therapeutics Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of BCAX in Q1 2025
Institution	Shares, Q4 2024	Value, Q4 2024
Deerfield Management Company, L.P. (Series C)	1,795,174	$31.3M
Alliancebernstein L.P.	821,264	$14.3M
First Turn Management, LLC	346,170	$6.03M
Boxer Capital Management, LLC	135,000	$2.35M
Marshall Wace, LLP	67,733	$1.18M
Maven Securities LTD	25,000	$435.5K
Verition Fund Management LLC	21,630	$376.8K
Cinctive Capital Management LP	16,984	$295.9K
LMR Partners LLP	15,150	$263.9K
SG Americas Securities, LLC	8,411	$147.0K
Virtus ETF Advisers LLC	3,939	$68.6K
STRS Ohio	3,600	$62.7K
Spire Wealth Management	1,804	$31.4K
R Squared Ltd	1,040	$18.1K
Advisor Group Holdings, Inc.	255	$4.44K
Aster Capital Management (DIFC) Ltd	77	$1.34K
Caitong International Asset Management Co., Ltd	76	$1.32K
MRP Capital Investments, LLC	20	$349

Not filed for Q1 2025 yet (1)

Institutions that held Bicara Therapeutics Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding BCAX in Q4 2024 that haven't filed for Q1 2025
Institution	Shares, Q4 2024	Value, Q4 2024
Nuveen Asset Management, LLC	25,028	$436.0K